Mesoblast Ltd Files Annual Report

Ticker: MEOBF · Form: 6-K · Filed: Oct 28, 2025 · CIK: 1345099

Mesoblast LTD 6-K Filing Summary
FieldDetail
CompanyMesoblast LTD (MEOBF)
Form Type6-K
Filed DateOct 28, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: annual-report, filing

TL;DR

MESOBLAST LTD FILED ITS ANNUAL REPORT ON 10/28/2025 - CHECK IT OUT.

AI Summary

On October 28, 2025, Mesoblast Limited filed its Annual Report to Shareholders with the Australian Securities Exchange. The report is incorporated into this Form 6-K filing. Mesoblast Limited is incorporated in Australia and its fiscal year ends on June 30.

Why It Matters

This filing provides shareholders and the public with an update on the company's performance and activities over the past fiscal year.

Risk Assessment

Risk Level: low — This is a routine annual report filing and does not contain new material financial or operational information that would significantly alter risk.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose is to report Mesoblast Limited's Annual Report to Shareholders, filed with the Australian Securities Exchange on October 28, 2025.

When does Mesoblast Limited's fiscal year end?

Mesoblast Limited's fiscal year ends on June 30.

Who is the Chief Executive Officer and Executive Director of Mesoblast Limited?

Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.

Where is Mesoblast Limited's principal executive office located?

Mesoblast Limited's principal executive office is located at Level 38, 55 Collins Street, Melbourne, Victoria, 3000, Australia.

Does Mesoblast Limited file an annual report on Form 20-F or 40-F?

Mesoblast Limited indicates it files an annual report on Form 20-F.

Filing Stats: 308 words · 1 min read · ~1 pages · Grade level 14.7 · Accepted 2025-10-27 19:56:10

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated October 28, 2025 INDEX TO EXHIBITS Item 99.1 Annual Report to Shareholders of Mesoblast Ltd, dated October 28, 2025. 99.2 Notice of Annual General Meeting of Mesoblast Ltd , dated October 28, 2025 99.3 Appendix 4G and Corporate Governance Statement of Mesoblast Ltd, dated October 28, 2025

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing